Skip to main content

Advertisement

Log in

Time to Depression Treatment in Primary Care Among HIV-infected and Uninfected Veterans

  • Original Research
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

BACKGROUND

Multiple factors, including patient characteristics, competing demands, and clinic type, impact delivery of depression treatment in primary care.

OBJECTIVE

Assess whether depression severity and HIV serostatus have a differential effect on time to depression treatment among depressed patients receiving primary care at Infectious Disease or General Medicine clinics.

DESIGN

Multicenter prospective cohort, (Veterans Aging Cohort Study), comparing HIV-infected to uninfected patients.

PARTICIPANTS AND MEASURES

The total cohort consisted of 3,239 HIV-infected and 3,227 uninfected patients. Study inclusion criteria were untreated depressive symptoms, based on a Patient Health Questionnaire (PHQ-9) score of greater than 9, and no antidepressants or mental health visits in the 90 days prior to PHQ-9 assessment. Treatment was defined as antidepressant receipt or mental health visit within 90 days following PHQ-9 assessment. Depression severity based on PHQ-9 scores was defined as mild-moderate (greater than 9 to 19) and severe (20 or greater). Kaplan-Meier curves were used to estimate time to treatment by depression severity and HIV serostatus. Cox proportional hazards methods adjusted for covariates were used.

KEY RESULTS

Overall, 718 (11%) of the cohort met inclusion criteria, 258 (36%) of whom received treatment. Median time to treatment was 7 days [95% confidence interval (CI) = 4, 13] and was shortest for severely depressed HIV-infected patients (0.5 days; 95% CI = 0.5, 6, p = 0.04). Compared to mildly-moderately depressed uninfected patients, severely depressed HIV-infected patients were significantly more likely to receive treatment [adjusted hazard ratio (HR) 1.67, 95% CI = 1.07, 2.60), whereas mildly-moderately depressed HIV-infected patients (adjusted HR 1.10, 95% CI = 0.79, 1.52) and severely depressed uninfected patients (adjusted HR 0.93, 95% CI = 0.60, 1.44) were not.

CONCLUSIONS

In this large cohort, time to primary care treatment of depression was shortest among severely depressed HIV-infected patients. Regardless of HIV serostatus, if depression was not treated on the assessment day, then it was unlikely to be treated within a 90-day period, leading to the majority of depression being untreated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–26.

    Article  PubMed  Google Scholar 

  2. Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–54.

    Article  CAS  PubMed  Google Scholar 

  3. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med. 1999;61:6–17.

    CAS  PubMed  Google Scholar 

  4. Treisman G, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2007;45(Suppl 4):S313–7.

    Article  PubMed  Google Scholar 

  5. Sternhell PS, Corr MJ. Psychiatric morbidity and adherence to antiretroviral medication in patients with HIV/AIDS. Aust NZ J Psychiatry. 2002;36:528–33.

    Article  Google Scholar 

  6. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.

    CAS  PubMed  Google Scholar 

  7. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54:295–306.

    Article  PubMed  Google Scholar 

  8. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–8.

    Article  CAS  PubMed  Google Scholar 

  9. Himelhoch S, Medoff DR. Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care ST. 2005;19:813–22.

    Article  Google Scholar 

  10. Himelhoch S, Medoff DR, Oyeniyi G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis. AIDS Patient Care ST. 2007;21:732–9.

    Article  Google Scholar 

  11. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569–80.

    Article  CAS  PubMed  Google Scholar 

  12. Vitiello B, Burnam MA, Bing EG, Beckman R, Shapiro MF. Use of psychotropic medications among HIV-infected patients in the United States. Am J Psychiatry. 2003;160:547–54.

    Article  PubMed  Google Scholar 

  13. Colibazzi T, Hsu TT, Gilmer WS. Human immunodeficiency virus and depression in primary care: a clinical review. Prim Care Companion J Clin Psychiat. 2006;8:201–11.

    Article  Google Scholar 

  14. Nutting PA, Rost K, Smith J, Werner JJ, Elliot C. Competing demands from physical problems: effect on initiating and completing depression care over 6 months. Arch Fam Med. 2000;9:1059–64.

    Article  CAS  PubMed  Google Scholar 

  15. Sueoka K, Goulet JL, Fiellin DA, et al. Depression symptoms and treatment among HIV infected and uninfected veterans. AIDS Behav. Epub 2008 Jul 22.

  16. Ani C, Bazargan M, Hindman D, Bell D, Rodriguez M, Baker RS. Comorbid chronic illness and the diagnosis and treatment of depression in safety net primary care settings. J Am Board Fam Med. 2009;22:123–35.

    Article  PubMed  Google Scholar 

  17. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): Overview and description. Med Care. 2006;44:S13–24.

    Article  PubMed  Google Scholar 

  18. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158:1789–95.

    Article  CAS  PubMed  Google Scholar 

  19. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.

    Article  CAS  PubMed  Google Scholar 

  20. Fultz SL, Goulet JL, Weissman S, et al. Differences between infectious diseases-certified physicians and general medicine-certified physicians in the level of comfort with providing primary care to patients. Clin Infect Dis. 2005;41:738–43.

    Article  PubMed  Google Scholar 

  21. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282:1737–44.

    Article  CAS  PubMed  Google Scholar 

  22. Rollman BL, Weinreb L, Korsen N, Schulberg HC. Implementation of guideline-based care for depression in primary care. Adm Policy Ment Health. 2006;33:43–53.

    Article  PubMed  Google Scholar 

  23. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med. 2007;22:1596–602.

    Article  PubMed  Google Scholar 

  24. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. Clinical Practice Guideline, Number 5. Depression guideline panel: Depression in primary care: Volume 2. Treatment of major depression. 1993; AHCPR Publication No. 93-0551: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=hsarchive&part=A15593. Accessed February 15, 2010.

  25. Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: treating depression in the real world. Cleve Clin J Med. 2008;75:57–66.

    Article  PubMed  Google Scholar 

  26. Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians—American Society of Internal Medicine. Ann Intern Med. 2000;132:209–18.

    CAS  PubMed  Google Scholar 

  27. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol. 1999;19:132–40.

    Article  CAS  PubMed  Google Scholar 

  28. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000.

  29. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med. 2008;121:S8–15.

    Article  PubMed  Google Scholar 

  30. Lippi G, Montagnana M, Favaloro EJ, Franchini M. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost. 2009;35:325–36.

    Article  PubMed  Google Scholar 

  31. Borowsky SJ, Rubenstein LV, Meredith LS, Camp P, Jackson-Triche M, Wells KB. Who is at risk of nondetection of mental health problems in primary care? J Gen Intern Med. 2000;15:381–8.

    Article  CAS  PubMed  Google Scholar 

  32. Das AK, Olfson M, McCurtis HL, Weissman MM. Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract. 2006;55:30–9.

    PubMed  Google Scholar 

  33. Nelligan JA, Loftis JM, Matthews AM, Zucker BL, Linke AM, Hauser P. Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review. J Clin Psychiatry. 2008;69:810–6.

    Article  CAS  PubMed  Google Scholar 

  34. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. Gen Hosp Psych. 1996;18:61–5.

    Article  CAS  Google Scholar 

  35. Klinkman MS. Competing demands in psychosocial care. A model for the identification and treatment of depressive disorders in primary care. Gen Hosp Psych. 1997;19:98–111.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was funded by National Institute on Alcohol and Alcohol Abuse (U01 AA 13566 and U10 AA 13566), National Institute of Aging (K23 AG00826), Robert Wood Johnson Generalist Faculty Scholar Award, an Inter-agency Agreement between NIA, National Institute of Mental Health, and VA HSR&D Research Enhancement Award Program (REAP) PRIME Project (REA 08-266).

Conflict of Interest

None disclosed.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Amy C. Justice MD, PhD.

Additional information

The views expressed here are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.

Funding

National Institute on Alcohol and Alcohol Abuse (U01 AA 13566 and U10 AA 13566), National Institute of Aging (K23 AG00826), Robert Wood Johnson Generalist Faculty Scholar Award, an Inter-agency Agreement between NIA, National Institute of Mental Health, and VA HSR&D Research Enhancement Award Program (REAP) PRIME Project (REA 08-266).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hooshyar, D., Goulet, J., Chwastiak, L. et al. Time to Depression Treatment in Primary Care Among HIV-infected and Uninfected Veterans. J GEN INTERN MED 25, 656–662 (2010). https://doi.org/10.1007/s11606-010-1323-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-010-1323-z

KEY WORDS

Navigation